Resectable gastric cancer: operative mortality and survival analysis - PubMed (original) (raw)
Affiliations
- PMID: 12079155
Free article
Resectable gastric cancer: operative mortality and survival analysis
Chia-Siu Wang et al. Chang Gung Med J. 2002 Apr.
Free article
Abstract
Background: This study evaluated the survival outcome and determined the prognostic factors for gastric cancer patients who underwent gastric resection in the past 6 years.
Methods: Between 1994 and 2000, a total of 1,322 patients with gastric cancer who underwent gastric resection in our hospital comprised the study subjects. Their mean age was 61.1 (range, 14-92) years. There were 865 male and 457 female patients. Total gastrectomy was performed in 389 (29.4%) and distal gastrectomy in 933 patients. Curative resection was performed in 961, and palliative resection in 361 patients. A D2 or greater lymphadenectomy was required for curative resection. Patients received postoperative chemotherapy if they underwent palliative resection.
Results: Early or pT1 gastric cancer accounted for 17.7% and lymph node metastasis for 62.1% of all resected cases. The overall operative mortality and morbidity rates were 3.3% and 18.0%, respectively. The operative mortality for palliative total gastrectomy was particularly high (8.5%). The overall cumulative 5-year survival rate of all resected patients was 45.6%, and it was 57.0% after curative resection. Multivariate analysis revealed that lymph node metastasis, serosal invasion, peritoneal seeding, positive resection margin, liver metastasis, old age, tumor size, and lymphatic invasion were independent prognostic factors.
Conclusion: The most important prognostic factors for survival were lymph node metastasis, serosal invasion, peritoneal seeding, positive resection margin, liver metastasis, old age, tumor size, and lymphatic invasion. The operative mortality and survival outcome of our gastric cancer patients after gastric resection compared favorably with those of other series in other countries.
Similar articles
- Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis.
Huang CM, Wang JB, Lu HS, Zheng CH, Li P, Xie JW, Zhang XF. Huang CM, et al. Chin Med J (Engl). 2009 Nov 20;122(22):2757-62. Chin Med J (Engl). 2009. PMID: 19951610 - Multivariate prognostic study on large gastric cancer.
Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Shiraishi N, et al. J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631. J Surg Oncol. 2007. PMID: 17582596 Review. - Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
Min JS, Jin SH, Park S, Kim SB, Bang HY, Lee JI. Min JS, et al. Ann Surg Oncol. 2012 Feb;19(2):494-501. doi: 10.1245/s10434-011-1987-6. Epub 2011 Aug 12. Ann Surg Oncol. 2012. PMID: 21837527 - Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ. Sheen-Chen SM, et al. Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94. Hepatogastroenterology. 1997. PMID: 9356878 - Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors.
Zhou Y, Yu F, Wu L, Ye F, Zhang L, Li Y. Zhou Y, et al. Med Sci Monit. 2015 Jul 2;21:1911-9. doi: 10.12659/MSM.893856. Med Sci Monit. 2015. PMID: 26134762 Free PMC article. Review.
Cited by
- Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.
Cheng WL, Tsai MM, Tsai CY, Huang YH, Chen CY, Chi HC, Tseng YH, Chao IW, Lin WC, Wu SM, Liang Y, Liao CJ, Lin YH, Chung IH, Chen WJ, Lin PY, Wang CS, Lin KH. Cheng WL, et al. PLoS One. 2012;7(3):e34352. doi: 10.1371/journal.pone.0034352. Epub 2012 Mar 29. PLoS One. 2012. PMID: 22479608 Free PMC article. - Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis.
Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng Y, Fang W, Xu N, Teng L. Deng J, et al. PLoS One. 2014 Feb 21;9(2):e88907. doi: 10.1371/journal.pone.0088907. eCollection 2014. PLoS One. 2014. PMID: 24586437 Free PMC article. Review. - Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.
Tsai MM, Lin PY, Cheng WL, Tsai CY, Chi HC, Chen CY, Tseng YH, Cheng YF, Chen CD, Liang Y, Liao CJ, Wu SM, Lin YH, Chung IH, Wang CS, Lin KH. Tsai MM, et al. Cancer Sci. 2012 Jun;103(6):1136-44. doi: 10.1111/j.1349-7006.2012.02243.x. Epub 2012 Mar 28. Cancer Sci. 2012. PMID: 22348287 Free PMC article. - Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer.
Shin D, Park SS. Shin D, et al. World J Gastrointest Oncol. 2013 Jan 15;5(1):4-11. doi: 10.4251/wjgo.v5.i1.4. World J Gastrointest Oncol. 2013. PMID: 23738049 Free PMC article. - ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
Zhang M, Zhang C, Du W, Yang X, Chen Z. Zhang M, et al. Clin Transl Oncol. 2016 Aug;18(8):776-81. doi: 10.1007/s12094-015-1430-8. Epub 2015 Nov 2. Clin Transl Oncol. 2016. PMID: 26527032
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous